Skip to main content

Table 2 K-TEA Mean Baseline-to-Endpoint Scores

From: Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia

K-TEA Score, Mean (SE)

Group

Baseline

Endpoint

Change

Reading decoding standard

ADHD

94.3 (9.1)

100.2 (13.5)

3.9 (2.1)

 

ADHD+D

80.2 (7.6)

84.8 (10.6)

5.6 (1.8)a

Reading decoding age equiv, mo

ADHD

137.7 (30.6)

158.1 (40.9)

17.8 (5.3)a

 

ADHD+D

104.0 (12.2)

115.5 (22.2)

16.9 (5.7)a

Spelling standard

ADHD

90.2 (15.6)

93.0 (16.9)

3.2 (1.1)a

 

ADHD+D

80.1 (8.6)

82.1 (10.0)

1.5 (1.0)

Spelling age equiv, mo

ADHD

132.6 (40.4)

140.6 (41.6)

9.7 (2.4)a

 

ADHD+D

106.3 (18.9)

112.1 (25.7)

8.7 (2.2)a

Reading comprehension standard

ADHD

98.9 (14.0)

104.0 (15.2)

5.6 (2.0)a

 

ADHD+D

81.6 (10.8)

89.3 (13.8)

9.8 (1.7)a

Reading comprehension age equiv, mo

ADHD

148.4 (41.0)

163.5 (43.8)

17.0 (5.7)a

 

ADHD+D

106.5 (23.6)

124.8 (35.6)

26.0 (5.2)a

Reading composite standard

ADHD

96.6 (11.6)

102.6 (14.9)

4.5 (1.8)a

 

ADHD+D

80.3 (8.6)

86.4 (11.4)

8.1 (1.6)a

Reading composite age equiv, mo

ADHD

144.3 (35.8)

161.9 (40.2)

17.2 (4.4)a

 

ADHD+D

105.3 (16.6)

120.9 (26.5)

23.5 (4.3)a

  1. Last Observation Carried Forward LS Mean Change with no adjustments for number of tests conducted.
  2. a p-value ≤ .05 for within-group changes.
  3. Abbreviations: ADHD = attention-deficit/hyperactivity disorder group; ADHD+D = ADHD and dyslexia group; equiv = equivalent; mo = months; SE = standard error; K-TEA = Kaufman Test of Educational Achievement.